05/08/2019
3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) |  |
04/26/2019
3:39 PM | Sarepta Therapeutics (Filer)
| Form DEFA14A
| |
04/26/2019
3:22 PM | Sarepta Therapeutics (Filer)
| Form DEF 14A
| |
04/05/2019
7:30 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/29/2019
7:01 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
7:00 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/29/2019
6:59 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/28/2019
7:38 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2019
4:16 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/25/2019
7:30 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/20/2019
7:00 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2019
8:12 AM | Sarepta Therapeutics (Filer)
| Form 424B5
| |
03/07/2019
8:00 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/04/2019
7:09 PM | O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:08 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:07 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:06 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:05 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:05 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:04 PM | GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:03 PM | BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:02 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2019
7:01 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/28/2019
6:38 AM | Sarepta Therapeutics (Filer)
| Form S-3ASR
| |
02/28/2019
6:07 AM | Sarepta Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/14/2019
12:48 PM | PRICE T ROWE ASSOCIATES INC /MD/ (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G
| |
02/14/2019
12:41 PM | Sarepta Therapeutics (Subject)
SUSQUEHANNA SECURITIES (Filed by)
| Form SC 13G/A
| |
02/14/2019
7:44 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/13/2019
8:48 AM | Sarepta Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/08/2019
7:02 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/06/2019
4:27 PM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A
| |
02/01/2019
7:27 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2019
7:25 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
02/01/2019
7:24 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
01/07/2019
9:59 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/20/2018
7:55 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2018
7:42 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/11/2018
7:38 AM | GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2018
7:37 AM | GRAY MARY ANN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
12/07/2018
4:02 PM | Sarepta Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
11/09/2018
4:15 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
11/09/2018
4:12 PM | Sarepta Therapeutics (Filer)
| Form 424B5
| |
11/09/2018
3:41 PM | Sarepta Therapeutics (Filer)
| Form CT ORDER
| |
11/08/2018
5:09 AM | Sarepta Therapeutics (Filer)
| Form 424B5
| |
11/02/2018
5:01 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/02/2018
5:00 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/31/2018
3:24 PM | Sarepta Therapeutics (Filer)
| Form 10-Q/A
| |
10/31/2018
3:04 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
10/30/2018
6:05 PM | INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/26/2018
5:43 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/24/2018
3:13 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
10/03/2018
4:18 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/24/2018
6:05 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
09/21/2018
5:40 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/16/2018
6:30 AM | INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
5:16 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
5:14 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
5:14 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/08/2018
3:36 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/01/2018
4:10 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
07/17/2018
5:01 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/11/2018
5:05 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/29/2018
5:01 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2018
4:24 PM | INGRAM DOUGLAS S (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/27/2018
4:16 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/19/2018
9:41 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
06/11/2018
5:11 PM | O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2018
5:09 PM | O'Neill Gilmore Neil (Reporting)
Sarepta Therapeutics (Issuer)
| Form 3
Initial statement of beneficial ownership of securities | |
06/06/2018
3:45 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/24/2018
5:06 PM | Ruff Shamim (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2018
5:05 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2018
5:05 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/24/2018
5:04 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/03/2018
3:03 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/03/2018
3:02 PM | Sarepta Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
04/26/2018
4:15 PM | Sarepta Therapeutics (Filer)
| Form DEFA14A
| |
03/16/2018
5:13 PM | Ruff Shamim (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2018
5:12 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2018
5:10 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/16/2018
5:08 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/12/2018
6:37 AM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/07/2018
5:06 PM | Sarepta Therapeutics (Issuer)
Wigzell Hans Lennart Rudolf (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:06 PM | Ruff Shamim (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:05 PM | Nicaise Claude (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:04 PM | Mahatme Sandesh (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:04 PM | Howton David T (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:03 PM | Cumbo Alexander (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:02 PM | BONNEY MICHAEL W (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:01 PM | BEHRENS M KATHLEEN (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:00 PM | Basi Guriqbal S. (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/07/2018
5:00 PM | Barry Richard (Reporting)
Sarepta Therapeutics (Issuer)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/01/2018
3:11 PM | Sarepta Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
03/01/2018
3:08 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2018
11:18 AM | Sarepta Therapeutics (Subject)
Tourbillon Capital Partners, L.P. (Filed by)
| Form SC 13G/A
| |
02/12/2018
12:42 PM | Sarepta Therapeutics (Subject)
VANGUARD GROUP INC (Filed by)
| Form SC 13G/A
| |
02/12/2018
9:01 AM | FMR LLC (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A
| |
02/09/2018
10:40 AM | Sarepta Therapeutics (Subject)
SUSQUEHANNA SECURITIES (Filed by)
| Form SC 13G/A
| |
01/23/2018
4:09 PM | BlackRock Inc. (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G/A
| |
01/08/2018
12:44 PM | Sarepta Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/21/2017
8:13 AM | CAPITAL VENTURES INTERNATIONAL (Filed by)
Sarepta Therapeutics (Subject)
| Form SC 13G
| |
